Navigation Links
DaVita Clinical Research Completes Record Number of Renal Trials in 2007
Date:5/8/2008

Nation's Largest Renal Research Network Completes 13 Phase-I Clinical

Trials; Reports Another 34 Active Trials in Late Stage Development

EL SEGUNDO, Calif., May 8 /PRNewswire/ -- DaVita Clinical Research(R) (DCR), a Phase I-IV clinical trial research service business specializing in renal-related drug and device research and development for FDA approval, reports it completed 13 Phase-I clinical trials in 2007 and has another 34 active trials in late stage drug development-a company record.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DCR(R), through its commitment to quality, timely and accurate clinical trials, plays a valuable role by partnering with physicians, pharmaceutical and biotechnology companies to develop and progress new drug therapies for patients diagnosed with chronic kidney disease (CKD). The increase in completed and late stage trials also serves as an indication of continued innovation and investment for end stage renal disease (ESRD) research.

"The recent DaVita Clinical Research accomplishments can be attributed to our continuous research quality index measurements and commitment to service excellence," said Chris Rucker, DCR Vice President and General Manager. "These values serve as a catalyst for our research objectives, and allow us to participate in the advancement of renal knowledge and practice."

DCR has nearly two decades of experience in conducting Phase I-IV clinical trials, and is the nation's largest renal research network dedicated to providing and supporting clinical and data research. DCR provides Phase-I renal studies services including renal, Hepatic, CV, Dermatology and Endocrine subjects, Pharmacokinetics, Pharmacodynamics and drug interactions. Phase II- IV renal studies services include pre ESRD and ESRD subjects, clinical efficacy and safety, special populations and post marke
'/>"/>

SOURCE DaVita Clinical Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
2. Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
3. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
4. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
5. Go Healthy Initiates Additional Clinical Tests on Cholesterade
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
8. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
9. NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
10. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
11. Association of Clinical Research Organizations (ACRO) to Help Lead Clinical Trials Transformation Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... CITY , Aug. 27, 2014 Varian Medical ... expand its current Salt Lake City ... underway outside of Utah to ultimately ... the next 20 years. " Utah ... and technical talent, many of whom can be credited with ...
(Date:8/27/2014)... 27, 2014   Los Angeles orthodontics expert, ... to patients who want to make their treatment even ... the OrthoSpaceship, all patients have a powerful tool to ... can be used by most patients with all types ... by using the AcceleDent® Aura system for a few ...
(Date:8/27/2014)... August 27, 2014 According ... Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current Trends, ... MarketsandMarkets, the global Dental Equipment Market is expected to ... in 2014, growing at a CAGR of 5.7% ... market data tables and 61 figures spread through ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3
... 22, 2011 Mylan Inc. (Nasdaq: MYL ... of the Mylan Institutional business, has entered a license ... treatment products company, for the exclusive U.S. distribution rights ... Netherlands, has a portfolio that includes products used by ...
... 2011 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... today that they have entered into a long-term ... of XIAFLEX® (collagenase clostridium histolyticum), a novel, first-in-class ... Peyronie,s disease.  Under the terms of the agreement, ...
Cached Medicine Technology:Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio 2Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 2Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 3Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 4Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 5Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 6Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan 7
(Date:8/28/2014)... Baltimore, MD (PRWEB) August 28, 2014 ... has received Diamond level Allergan Privilege Program status ... widely used treatments as Botox, Juvederm, and Voluma. Maryland ... exemplary and prolific use of these treatments. The dermatologists ... in injectable treatments, and are one of the leading ...
(Date:8/28/2014)... 2014 Altec Products, Inc., a ... announced today that they have been awarded the ... of the International Association of Microsoft Channel Partners ... founded in 1994, providing Microsoft Partners with a ... community at large while facilitating mutual growth and ...
(Date:8/28/2014)... Dr. Bryan McIntosh of Bellevue, WA has ... to the tummy tuck cosmetic procedure, leading women through ... and how to recover well afterwards. , The ... also discusses how to have accurate expectations of the ... is as successful as possible. , To learn more ...
(Date:8/28/2014)... August 28, 2014 Dr. Stewart ... young patients throughout the summer that recently headed off ... Education Statistics, over 22 million students will attend ... may spend their time attending classes, studying for exams, ... their risk of eye problems. , Dr. Stewart ...
(Date:8/28/2014)... 2014 Postcard-worthy views, star-laden skies, romantic ... by the beach in your own private bungalow make ... at the Islands of Loreto. , The newest member ... experience in paradise with its romantic Honeymoon package, when ... , “Villa del Palmar at the Islands of Loreto ...
Breaking Medicine News(10 mins):Health News:Maryland Laser Skin and Vein Receives Diamond Status From Allergan 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 4
... Dr. Holmquist Healthcare, LLC Revolutionizes the Future of Bruise ... is pleased to announce the launch of Bruise Relief(TM), ... appearance of bruising, at CVS stores and other fine ... or serum formulation and is designed to super-hydrate the ...
... Attitude could affect care patients might get, experts warn ... percent of those training to be dietitians have positive ... the rest are moderately biased against their prospective patients, ... that future dieticians are not immune to weight bias, ...
... March 5 Yesterday,s Supreme Court ruling against preemption ... research for new therapies, and clearly elevates trial lawyers ... drug safety. The high court has decided that federal ... drug safety, and consequently, a flood of frivolous liability ...
... new study headed by Dr. Tom Feasby, Dean of ... behind other countries in the number of diagnostic imaging ... long wait times. The study,s authors say it is ... , "This study shows there are important deficiencies ...
... more than 3,000 women in the U.S. and southern ... a vaginal microbicide gel for preventing HIV infection in ... Retroviruses and Opportunistic Infections (CROI), one 0.5 % dose ... to cells in the genital tract, was 30% effective. ...
... WORTH, Texas, March 5 LifeSynch, a health ... been selected by Norfolk Southern Corp. ( http://www.nscorp.com ... nutrition, weight management, fitness and health coaching services ... its program called WellNS, Norfolk Southern provides an ...
Cached Medicine News:Health News:Say Goodbye to Unsightly Bruises and Skin Discolorations with Bruise Relief(TM) 2Health News:Bias Against Obesity Is Found Among Future Dietitians 2Health News:Bias Against Obesity Is Found Among Future Dietitians 3Health News:High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers 2Health News:Lack of strategies to manage MRI wait lists a key reason for excessive wait times 2Health News:Clinical trial finds microbicide promising as HIV prevention method for women 2Health News:LifeSynch Chosen to Provide Wellness Services to Norfolk Southern 2
Patient-Centered Therapy that promotes natural cardiac function....
The ACP 215 is the automated closed system cell processor with integrated process control....
... Durability for Excellent Access. Access ... challenging cases. PT² wires combine ... linear elastic nitinol distal core ... tip. This provides excellent access ...
... The PCS2 system ... for the collection of ... allow for the collection ... platelet-poor plasma, platelet-poor plasma ...
Medicine Products: